4CPS-230 Allogeneic haematopoietic cell transplantation in patients aged <60 years with acute myeloid leukemia

Abstract

on the documentation available at the point-of-care ('Hospital list'), which in turn got validated via NEHR data ('NEHR list'), with the final step being a patient interview, formulating the final medication list ('BPMH list'). Primary outcome metrics were the frequency and types of medication discrepancies derived from the comparison of the aforementioned lists, including the former SoC. ResultsThe study included 100 patients (52% female, average age=62 years). 231 discrepancies were found between the NEHR list and the Hospital list (median=2; IQR=4), 64% of the patients being affected. The most common discrepancy was drug omission (65%) and incorrect daily dose (26%). There was an inconsistency between the BPMH list and the SoC in 90% of the patients (median=3; IQR=3), the most common errors being drug omission (41%) and incorrect daily dose (31%). Conclusion and RelevanceBased on these results, the NEHR can contribute to the compilation of a more prudent BPMH due to its more comprehensive data content. This methodology may, in turn, facilitate the prevention of multiple medication-related errors. These outcomes also underline the legitimacy of pharmacists' access to such national systems.